Skip to main content

Table 2 Analysis of associations between TNFA-308G/A, IL6-174G/C and IFNG + 874 T/A polymorphisms and risk of HAM/TSP development

From: Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil

Polymorphisms

HAM/TSP

Asymptomatic

  

n (%)

n (%)

OR (IC:95%)

p-value

TNFA-308G/A

 GG

55 (82.1)

69 (83.1)

1

0.98

 GA

12 (17.9)

13 (15.7)

1.16 (0.48–2.75)

 

 AA

0

1 (1.2)

0 (NA)

 

 GG (low)

55 (82.1)

69 (83.1)

1

1

 GA + AA (high)

12 (17.9)

14 (16.9)

1.08 (0.45–2.52)

 

 AA

0

1 (1.2)

1

1

 GA + GG

67 (100)

82 (98.8)

0 (NA)

 

Alleles

  G

122 (91.0)

151 (91.0)

1

1

  A

12 (9.0)

15 (9.0)

0.99 (0.44–2.19)

 

IL6-174G/C

 GG

48 (71.6)

56 (68.3)

1

0.88

 GC

16 (23.9)

24 (29.3)

0.78 (0.37–1.62)

 

 CC

3(4.5)

2 (2.4)

1.75 (0.28–13.7)

 

 CC (low)

3 (4.5)

2 (2.4)

1

0.66

 GC + GG (high)

64 (95.5)

80 (97.6)

0.53 (0.07–3.31)

 

 GG

48 (71.6)

56 (68.3)

1

0.79

 GC + CC

19 (28.4)

26 (31.7)

0.85 (0.42–172)

 

Alleles

  G

112(83.6)

136 (82.9)

1

1

  C

22 (16.4)

28 (17.1)

0.95 (0.51–1.76)

 

IFNG + 874 T/A

 AA (low)

34 (50.7)

34 (43.6)

1

0.86

 AT (intermediate)

26 (38.8)

40 (51.3)

0.65 (0.33–1.29)

 

 TT (high)

7(10.4)

4 (5.1)

1.75 (0.48–7.20)

 

 AA

34 (50.7)

34 (43.6)

1

0.49

 AT+TT

33 (49.3)

44 (56.4)

0.75 (0.39–1.44)

 

 TT

7 (10.4)

4 (5.1)

1

0.35

 AT+AA

60 (89.6)

74 (94.9)

0.46 (0.12–1.61)

 

Alleles

  A

94 (70.1)

108 (69.2)

1

0.97

  T

40 (29.9)

48 (30.8)

0.96 (0.58–1.58)

 
  1. HAM/TSP HTLV-1 associated myelopathy tropical spastic paraparesis, Asymptomatic HTLV-1 patients, OR odds ration with confident interval, Chi-square 2 × 2 or 3 × 2 contingent tables, Fisher exact or Cochran-Armitage tests